David Callecod

President and CEO
Callecod Advisory Group

David L. Callecod launched Callecod Advisory Group LLC (CAG) in December 2022. CAG provides early-stage health startups with knowledge, expertise and experience in both the legacy volume-based and the evolving value-based healthcare delivery system. Having led the formation of two successful Innovation Funds within a health system, Callecod provides guidance with navigating the healthcare landscape, forming partnerships with health systems, and developing go-to-market strategies. To date, the CAG portfolio includes ActOne Health, Adjuvant Behavioral Health, Authenticx, Bishop, Performance Health Partners, Kwema, Junum, Obatala, BioSapien, alviss.ai, Aptus Life, GosiaGenomics, Kioma, Oui Medical, Quantiface, SageSpectra, Tenets AI, Ultrasonic Medical Mapping, VenoVision, Vivifi and Winter Innovations. Callecod participates in the New Louisiana Angel Fund and Health Wildcatters Accelerator. He also serves as a mentor/advisor in Louisiana Startup Prize, MassChallenge, and Abundant Venture Partners.

Callecod served in executive roles within health systems for over 33 years and most recently served as Interim CEO of Ochsner LSU North Louisiana in 2022. Prior to that, he served as President/CEO of Lafayette General Health (now Ochsner Lafayette General) from 2008-2021. During his tenure in Lafayette, the health system grew from $170M to $1B in annual revenues and received numerous awards for exceptional quality, patient satisfaction, and staff engagement.

Callecod was inducted into StuderGroup’s Healthcare Hall of Fame in October 2011 and is a national speaker on healthcare management and culture change. He received his BA from Wabash College, his MBA from Indiana Wesleyan University and is a Fellow of the American College of Healthcare Executives. He previously served as Chair of the Louisiana Hospital Association, the Wabash College Board of Trustees and was named Distinguished Alumnus by Indiana Wesleyan University in 2007.